Vyriad: Funding, Investors & Team (Oct 2026)
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami.
Vyriad has raised $54.5M across 2 funding rounds on record, the most recent a Series B of $25.0M announced in Dec 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vyriad Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Vyriad Funding Rounds
Vyriad raised $29.5M in a Series B announced in May 2022.
3.6 years later, a Series B of $25.0M was announced in Dec 2025.
Vyriad Founders and Leadership Team
Contact details for the Vyriad team: 1 of 2 have an email address on file.
Start 14-day free trial →Vyriad Funding Compared to Other Biotechnology Startups
Vyriad's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vyriad in Biotechnology and Rochester
Companies Similar to Vyriad
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Vyriad Funding FAQs
What does Vyriad do?
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami.
How much funding has Vyriad raised?
Vyriad has raised $54.5M across 2 rounds on record. The most recent is a Series B of $25.0M announced in Dec 2025.
When did Vyriad last raise funding?
Vyriad's most recent funding round on record is a Series B of $25.0M, announced in Dec 2025.
Who founded Vyriad?
FundedIQ lists Kah Whye Peng (Founder), Kah-Whye Peng (Founder) at Vyriad.
Where is Vyriad headquartered?
Vyriad is based in Rochester, Minnesota, United States.
How many employees does Vyriad have?
Vyriad is in the 11-50 employee band.
How does Vyriad's funding compare to other Biotechnology startups?
Vyriad's latest round of $25.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Vyriad Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vyriad is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.